An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice

American Journal of Chinese Medicine

Volumn 40, Issue 3, 2012, Pages 495-510

  Lee, An Sook ^a,b   Lee, Yun Jung ^a,b   Lee, So Min ^a,b   Yoon, Jung Joo ^a,b   Kim, Jin Sook ^c   Kang, Dae Gill ^a,b   Lee, Ho Sub ^a,b  

^a Wonkwang University   (South Korea)

^b Wonkwang University   (South Korea)

^c Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Diabetic Nephropathy; Inflammation; NF B; Portulaca oleracea; Renal Fibrosis; Tg 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CREATININE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; PORTULACA OLERACEA EXTRACT; ROSIGLITAZONE; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; FLUID INTAKE; GLUCOSE BLOOD LEVEL; IMMUNOHISTOLOGY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; MALE; MOUSE; NEPHRITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RENAL PROTECTION; TREATMENT DURATION; URINE VOLUME;

ANIMALS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRINKING; FIBROSIS; GLYCOSYLATION END PRODUCTS, ADVANCED; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; KIDNEY CORTEX; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHROSCLEROSIS; PHYTOTHERAPY; PLANT EXTRACTS; PORTULACA; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; URINATION;

EID: 84861519248     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500383     Document Type: Article

References (33)

1. Auwardt, R.B., S.J. Mudge, C. Chen and D.A. Power. Inhibition with antisense oligonucleotide suggests that Ikappa B-alpha does not form a negative autoregulatory loop for NF- B in mesangial cells. Exp. Nephrol. 8: 144-151, 2000. (Pubitemid 30313590)
2. Awad, N.E. Lipid content and antimicrobial activity of phenolic constituents of cultivated Portulaca oleracea L. Bull. Fac. Pharm. 32: 137-142, 1994.
3. Border, W.A. and N.A. Noble. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331: 1286-1292, 1994. (Pubitemid 24333194)
4. Chan, K., M.W. Islam, M. Kamil, R. Radhakrishnan, M.N.M. Zakaria, M. Habibullah and A. Attas. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J. Ethnopharmacol. 73: 445-451, 2000.
5. Eddy, A.A. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7: 2495-2508, 1996. (Pubitemid 27469555)
6. Forbes, J.M., M.E. Cooper, M.D. Oldfield and M.C. Thomas. Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14: S254-8, 2003. (Pubitemid 36903936)
7. Galkina, E. and K. Ley. Leukocyte recruitment and vascular injury in diabetic nephropathy. J. Am. Soc. Nephrol. 17: 368-377, 2006.
8. Gilbert, R.E., and M.E. Cooper. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 56: 1627-1637, 1999. (Pubitemid 29518163)
9. Iwamoto, M., S. Mizuiri, M. Arita and H. Hemmi. Nuclear factor- B activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy. Tohoku J. Exp. Med. 206: 163-171, 2005. (Pubitemid 40895046)
10. Jian, J.W. and Q.X. Xiao. Phytomedicine Effective Component Book. People's Hygiene Press, Beijing, 1986.
11. Kim, C.S., E.J. Sohn, Y.S. Kim, D.H. Jung, D.S. Jang, Y.M. Lee, D.H. Kim and J.S. Kim. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. J. Ethnopharmacol. 111: 240-247, 2007. (Pubitemid 46528078)
12. Lee, F.T., Z. Cao, D.M. Long, S. Panagiotopoulos, G. Jerums, M.E. Cooper and J.M. Forbes. Interactions between angiotensin II and NF- B-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J. Am. Soc. Nephrol. 15: 2139-2151, 2004. (Pubitemid 39031352)
13. Lee, Y.J., M.K. Moon, S.M. Hwang, J.J. Yoon, S.M. Lee, K.S. Seo, J.S. Kim, D.G. Kang and H.S. Lee. Anti-Inflammatory effect of Buddleja officinalis on vascular inflammation in human umbilical vein endothelial cells. Am. J. Chin. Med. 38: 585-598, 2010.
14. Leung, A.Y. and S. Foster. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 2nd ed. John Wiley, New York, 1996
15. Lopez-Franco, O., Y. Suzuki, G. Sanjuan, J. Blanco, P. Hernandez-Vargas, Y. Yo, J. Kopp, J. Egido and C. Gomez-Guerrero. Nuclear factor- B inhibitors as potential novel antiinflammatory agents for the treatment of immune glomerulonephritis. Am. J. Pathol. 161: 1497-1505, 2002.
16. Masson, E., L. Troncy, D. Ruggiero, N. Wiernsperger, M. Lagarde and S.E. Bawab. A-series gangliosides mediate the effects of advanced glycation end products of pericyte and mesangial cell proliferation: a common mediator for retinal and renal microangiopathy? Diabetes 54: 220-227, 2005. (Pubitemid 40105116)
17. Miyatake, N., K. Shikata, H. Sugimoto, M. Kushiro, Y. Shikata, S. Ogawa, Y. Hayashi, M. Miyasaka and H. Makino. Intercellular adhesion molecule 1 mediates mononuclear cell infiltration into rat glomeruli after renal ablation. Nephron 79: 91-98, 1998. (Pubitemid 28204044)
18. Navarro, J.F. and C. Mora. Role of inflammation in diabetic complications. Nephrol. Dial. Transplant. 20: 2601-2604, 2005. (Pubitemid 41672253)
19. Okada, S., K. Shikata, M. Matsuda, D. Ogawa, H. Usui, Y. Kido, R. Nagase, J. Wada, Y. Shikata, and H. Makino. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52: 2586-2593, 2003. (Pubitemid 37210549)
20. Park, C.W., J.H. Kim, J.H. Lee, Y.S. Kim, H.J. Ahn, Y.S. Shin, S.Y. Kim, E.J. Choi, Y.S. Chang and B.K. Bang. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF- B-dependent. Diabetologia 43: 1544-1553, 2000. (Pubitemid 32734862)
21. Parry, O., J.A. Marks and F. Okwuasaba. The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions. J. Ethnopharmacol. 40: 187-194, 1993. (Pubitemid 24012059)
22. Rashed, A.N., F.U. Afifi and A.M. Disi. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J. Ethnopharmacol. 88: 131-136, 2003. (Pubitemid 37083437)
23. Russo, L.M., E. del Re, D. Brown and H.Y. Lin. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes 56: 380-388. 2007.
24. Sakai, N., K. Inada, M. Okamoto, Y. Shizuri and Y. Fukuyama. Portuloside A, a monoterpene glucoside, from Portulaca oleracea. Phytochemistry 42: 1625-1628, 1996. (Pubitemid 27065660)
25. Schmid, H., A. Boucherot, Y. Yasuda, A. Henger, B. Brunner, F. Eichinger, A. Nitsche, E. Kiss, M. Bleich, H.J. Gröne, P.J. Nelson, D. Schlöndorff, C.D. Cohen and M. Kretzler. Modular activation of nuclear factor- B transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003, 2006. (Pubitemid 44923635)
26. Sharma, K., Y. Jin, J. Guo and F.N. Ziyadeh. Neutralization of TGF-beta by anti-TGF beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZinduced diabetic mice. Diabetes 45: 522-530, 1996.
27. Shibuya, K., K. Kanasaki, M. Isono, H. Sato, M. Omata, T. Sugimoto, S. Araki, K. Isshiki, A. Kashiwagi, M. Haneda and D. Koya. N-acetyl-seryl-aspartyl- lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes 54: 838-845, 2005. (Pubitemid 40322089)
28. Sugimoto, H., K. Shikata, K. Hirata, K. Akiyama, M. Matsuda, M. Kushiro, Y. Shikata, N. Miyatake, M. Miyasaka and H. Makino. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 46: 2075-2081, 1997. (Pubitemid 27512099)
29. Wang, Z.P., S.X. Cai, D.B. Liu, X. Xu and H.P. Liang. Anti-inflammatory effects of a novel peptide designed to bind with NF- B p50 subunit. Acta. Pharmacol. Sin. 27: 1474-1478, 2006. (Pubitemid 44630316)
30. Wolf, G. and F.N. Ziyadeh. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56: 393-405, 1999. (Pubitemid 29353136)
31. Yamamoto, T., T. Nakamura, N.A. Noble, E. Ruoslahti and W.A. Border. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA 90: 1814-1818, 1993. (Pubitemid 23069947)
32. Yan, S.F., R. Ramasamy and A.M. Schmidt. Mechanisms of disease: advanced glycation endproducts and their receptor in inflammation and diabetes complications. Nat. Clin. Pract. Endocrinol. Metab. 4: 285-293, 2008. (Pubitemid 351571138)
33. Zhang, X.J., Y.B. Ji, Z.Y. Qu, J.C. Xia and L. Wang. Experimental studies on antibiotic functions of Portulaca oleracea L. in vitro. Chin. J. Microecol. 14: 277-280, 2002